Woonbok Chung

4.7k total citations · 2 hit papers
37 papers, 2.7k citations indexed

About

Woonbok Chung is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Woonbok Chung has authored 37 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Hematology and 7 papers in Cancer Research. Recurrent topics in Woonbok Chung's work include Epigenetics and DNA Methylation (26 papers), Acute Myeloid Leukemia Research (12 papers) and RNA modifications and cancer (11 papers). Woonbok Chung is often cited by papers focused on Epigenetics and DNA Methylation (26 papers), Acute Myeloid Leukemia Research (12 papers) and RNA modifications and cancer (11 papers). Woonbok Chung collaborates with scholars based in United States, Japan and South Korea. Woonbok Chung's co-authors include Jean‐Pierre J. Issa, Jaroslav Jelı́nek, Lanlan Shen, Marcos R. Estecio, Michael Ittmann, Bernard Kwabi‐Addo, Hagop M. Kantarjian, Minoru Toyota, Yutaka Kondo and Tomomitsu Tahara and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Woonbok Chung

35 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer

2015 513 citations Scott Kopetz, Jayesh Desai et al. Journal of Clinical Oncology profile →
Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma

2014 354 citations Tomomitsu Tahara, Eiichiro Yamamoto et al. Cancer Research profile →

Peers

Woonbok Chung

ONCOL

PRM

PFM

María Aparecida Nagai Brazil

Ines Gütgemann Germany

Yinghui Guan China

Richard Sesboüé France

Justin L. Ricker United States

Kazushi Inoue United States

Pornchai O‐charoenrat Thailand

Katrina Wood United Kingdom

Virote Sriuranpong Thailand

Suk Hang Cheng Hong Kong

María Aparecida Nagai Brazil

Woonbok Chung

1.6k ×0.9

619 ×0.7

ONCOL

417 ×0.8

267 ×0.6

PRM

301 ×0.7

PFM

Citations per year, relative to Woonbok Chung Woonbok Chung (= 1×) peers María Aparecida Nagai

Countries citing papers authored by Woonbok Chung

Since Specialization

Citations

This map shows the geographic impact of Woonbok Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Woonbok Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Woonbok Chung more than expected).

Fields of papers citing papers by Woonbok Chung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Woonbok Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Woonbok Chung. The network helps show where Woonbok Chung may publish in the future.

Co-authorship network of co-authors of Woonbok Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Woonbok Chung. A scholar is included among the top collaborators of Woonbok Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Woonbok Chung. Woonbok Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kropf, Patricia, Woonbok Chung, Lianchun Xiao, et al.. (2025). A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AML. PubMed. 2(2). 100071–100071.

Chung, Woonbok, Andrew D. Kelly, Patricia Kropf, et al.. (2019). Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia. Clinical Epigenetics. 11(1). 106–106. 20 indexed citations

Roboz, Gail J., Hagop M. Kantarjian, Karen Yee, et al.. (2017). Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia. Cancer. 124(2). 325–334. 49 indexed citations

Sato, Takahiro, Matteo Cesaroni, Woonbok Chung, et al.. (2016). Transcriptional Selectivity of Epigenetic Therapy in Cancer. Cancer Research. 77(2). 470–481. 49 indexed citations

Estecio, Marcos R., Jiexin Zhang, Vassiliki Tzelepi, et al.. (2016). Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. Epigenetics. 11(3). 184–193. 44 indexed citations

Kopetz, Scott, Jayesh Desai, Emily Chan, et al.. (2015). Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer. Journal of Clinical Oncology. 33(34). 4032–4038. 513 indexed citations breakdown →

Issa, Jean‐Pierre J., Gail J. Roboz, David A. Rizzieri, et al.. (2015). Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study. The Lancet Oncology. 16(9). 1099–1110. 210 indexed citations

Tahara, Tomomitsu, Eiichiro Yamamoto, Hiromu Suzuki, et al.. (2014). Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma. Cancer Research. 74(5). 1311–1318. 354 indexed citations breakdown →

Tahara, Tomomitsu, Shinji Maegawa, Woonbok Chung, et al.. (2013). Examination of Whole Blood DNA Methylation as a Potential Risk Marker for Gastric Cancer. Cancer Prevention Research. 6(10). 1093–1100. 31 indexed citations

10.

Tahara, Tomomitsu, Eiichiro Yamamoto, Priyanka Madireddi, et al.. (2013). Colorectal Carcinomas With CpG Island Methylator Phenotype 1 Frequently Contain Mutations in Chromatin Regulators. Gastroenterology. 146(2). 530–538.e5. 63 indexed citations

11.

Chung, Woonbok, Jolanta Bondaruk, Jaroslav Jelı́nek, et al.. (2011). Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments. Cancer Epidemiology Biomarkers & Prevention. 20(7). 1483–1491. 127 indexed citations

12.

Jelı́nek, Jaroslav, Vazganush Gharibyan, Marcos R. Estecio, et al.. (2011). Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia. PLoS ONE. 6(7). e22110–e22110. 90 indexed citations

13.

Konishi, Kazuo, Yoshiyuki Watanabe, Lanlan Shen, et al.. (2011). DNA Methylation Profiles of Primary Colorectal Carcinoma and Matched Liver Metastasis. PLoS ONE. 6(11). e27889–e27889. 29 indexed citations

14.

Watanabe, Yoshiyuki, Ryan Castoro, Hyun Soo Kim, et al.. (2011). Frequent Alteration of MLL3 Frameshift Mutations in Microsatellite Deficient Colorectal Cancer. PLoS ONE. 6(8). e23320–e23320. 58 indexed citations

15.

Qin, Taichun, Ryan Castoro, Jaroslav Jelı́nek, et al.. (2011). Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome. PLoS ONE. 6(8). e23372–e23372. 109 indexed citations

16.

Kwabi‐Addo, Bernard, Songping Wang, Woonbok Chung, et al.. (2010). Identification of Differentially Methylated Genes in Normal Prostate Tissues from African American and Caucasian Men. Clinical Cancer Research. 16(14). 3539–3547. 98 indexed citations

17.

Estecio, Marcos R., Juan Gallegos, Céline Vallot, et al.. (2010). Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Research. 20(10). 1369–1382. 67 indexed citations

18.

Ahn, Joong Bae, Woonbok Chung, Osamu Maeda, et al.. (2010). DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer. 117(9). 1847–1854. 133 indexed citations

19.

Chung, Woonbok, Bernard Kwabi‐Addo, Michael Ittmann, et al.. (2008). Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling. PLoS ONE. 3(4). e2079–e2079. 99 indexed citations

20.

Shu, Jingmin, Jaroslav Jelı́nek, Hao Chang, et al.. (2006). Silencing of Bidirectional Promoters by DNA Methylation in Tumorigenesis. Cancer Research. 66(10). 5077–5084. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact